A New Cardiac Rehabilitation Treatment in the Application of Ischemic Heart Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorShanghai 10th People's Hospital
About this trial
Cardiac rehabilitation is an important link in cardiovascular disease. This study mainly explores the effectiveness of new cardiac rehabilitation therapy (early respiratory rehabilitation, phase I rehabilitation, exercise therapy, external counterpulsation, extracorporeal shock wave, etc.) on patients with ischemic heart disease such as coronary heart disease and heart failure, and the compliance of home rehabilitation compared with traditional cardiac rehabilitation therapy (traditional exercise rehabilitation, rehabilitation education, etc.).
Eligibility criteria
Qualifiers
Aged between 18 and 85 years old
Female subjects no pregnancy
The main admission diagnosis of ischemic heart disease (coronary heart disease, myocardial infarction, ischemic heart failure, etc.)
The need for cardiac rehabilitation treatment
Disqualifiers
acute respiratory distress syndrome (ARDS);
acute episode of COPD;
uncontrolled pulmonary infection;
acute heart failure; acute pulmonary embolism;
Trial design
Treatments tested in this trial
- Metronomic breathing, exercise rehabilitation, external counterpulsation, extracorporeal shock wave.
- bedside rehabilitation and breathing, balance, flexibility, movement rehabilitation
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Shanghai 10th People's Hospital
Lead sponsor
Shanghai Municipal Science and Technology Commission
Collaborator
Source ClinicalTrials.gov